Corvus Pharmaceuticals, Inc. (CRVS) Operating Lease, Payments USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2024.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $473 K, a 3.05% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $1.85 M, a 7.67% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.84 M, a 8.5% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.7 M, a 3.04% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.65 M, a 9.23% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.85 M $473 K +$14 K +3.05% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.84 M $461 K +$65 K +16.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $1.77 M $459 K +$26 K +6.01% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.75 M $460 K +$27 K +6.24% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.72 M $459 K +$26 K +6.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.7 M $396 K -$10 K -2.46% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $1.71 M $433 K +$20 K +4.84% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.69 M $433 K +$20 K +4.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.67 M $433 K +$20 K +4.84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $1.65 M $406 K +$31 K +8.27% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 $1.61 M $413 K +$36 K +9.55% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.58 M $413 K +$36 K +9.55% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.54 M $413 K +$36 K +9.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.51 M $375 K +$18 K +5.04% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $1.49 M $377 K +$14 K +3.86% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $1.47 M $377 K +$7 K +1.89% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $1.47 M $377 K +$18 K +5.01% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $1.45 M $357 K +$10 K +2.88% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $1.44 M $363 K +$20 K +5.83% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.42 M $370 K +$27 K +7.87% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $1.39 M $359 K +$3 K +0.84% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $1.39 M $347 K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 $343 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $343 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $356 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.